0001841392-22-000002.txt : 20220929 0001841392-22-000002.hdr.sgml : 20220929 20220929170900 ACCESSION NUMBER: 0001841392-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220929 DATE AS OF CHANGE: 20220929 EFFECTIVENESS DATE: 20220929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NQ PE Project Stingray Parent, L.P. CENTRAL INDEX KEY: 0001841392 IRS NUMBER: 861196692 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460339 FILM NUMBER: 221281402 BUSINESS ADDRESS: STREET 1: 4509 CREEDMOOR ROAD STREET 2: SUITE 403 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 9192615250 MAIL ADDRESS: STREET 1: 4509 CREEDMOOR ROAD STREET 2: SUITE 403 CITY: RALEIGH STATE: NC ZIP: 27612 D 1 primary_doc.xml X0708 D LIVE 0001841392 NQ PE Project Stingray Parent, L.P. 4509 Creedmoor Road, Suite 403 RALEIGH NC NORTH CAROLINA 27612 9192615250 CAYMAN ISLANDS None None Limited Partnership true 2020 (the "GP") NQ PE Project Stingray Parent GP, Ltd. c/o QHP Capital, L.P. 4509 Creedmoor Road, Suite 403 Raleigh NC NORTH CAROLINA 27612 Executive Officer The general partner of the Issuer. Jeffrey Edwards c/o QHP Capital, L.P. 4509 Creedmoor Road, Suite 403 Raleigh NC NORTH CAROLINA 27612 Director Director of the GP. E. Ashton Poole c/o QHP Capital, L.P. 4509 Creedmoor Road, Suite 403 Raleigh NC NORTH CAROLINA 27612 Director Director of the GP. Pharmaceuticals Decline to Disclose 06b false 2022-09-14 false true Limited Partnership Interests. false 0 16240000 11421413 4818587 false 4 0 0 0 false NQ PE Project Stingray Parent, L.P. /s/ Heyward Armstrong Heyward Armstrong Attorney-in-Fact 2022-09-29